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The risk for upper extremity lymphedema post-mastectomy in women surgically 
treated for breast cancer is a concern since it is often painful, aesthetically displeasing, and 
can increase the risk of infection.  However, there is a paucity of data examining if 
diagnostic procedures performed in the ipsilateral arm post-mastectomy increases the risk 
of lymphedema. The purpose of this research is to examine the relationship between 
diagnostic procedures performed in the ipsilateral arm post-mastectomy and the 
occurrence of lymphedema with or without related complications. A systematic review of 
the literature was conducted from multiple, online databases available from 1992 through 
2014, and included CINAHL, MedLine, PsychInfo, and ERIC. Search terms included 
lymphedema, breast cancer, mastectomy, blood pressure, and infection. Exclusion criteria 
comprised articles focused on male gender, primary lymphedema, metastases, survival, 
quality of life studies, reoccurrence breast cancer, breast conservation, lymphedema 
management, lymphedema, and lymphoma. The results of this study were inconclusive 
concerning a relationship between upper extremity lymphedema and procedures 
performed in the ipsilateral arm after mastectomy. This literature review outlines gaps in 
the data showing a need for more focused research on the causes of secondary 
lymphedema after breast cancer surgery with lymph node removal. Further research on 
the impact of diagnostic and other invasive procedures on the ispilateral arm after 
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Breast cancer affects an estimated 232,340 women yearly in the United States 
(Society, 2013).  A common surgical procedure for treatment of breast cancer is 
mastectomy (Breastcancer.org, 2014).  This surgical procedure is often completed in 
conjunction with sentinel lymph node biopsy of the ispilateral breast or a full axillary 
dissection, depending on the surgical site, for cancer staging purposes.  After the surgery, 
women are educated to avoid having their blood pressure, and other invasive and 
noninvasive procedures, such as phlebotomy, performed on their ipsilateral arm associated 
with the axillary lymph node removal (Cole, 2006).  Consequently, it has become common 
practice for health care providers to avoid performing any type of intervention to the 
woman’s ipsilateral arm for an indefinite period of time.  Avoidance of procedures using 
the affected arm is often advised regardless of the axillary lymph node procedure 
performed, whether it is a sentinel lymph node biopsy or a full axillary dissection.  The 
concern for avoiding procedures in the ipsilateral arm is that it could expose the woman to 
the risk of lymphedema, which is often painful, aesthetically displeasing, and can increase 
the risk of infection.  However, little data supports the practice that performing blood 
pressure measurements or establishing venous access in the ipsilateral arm increases the 









After a diagnosis of breast cancer is confirmed, 89.2% of women have a predicted 
survival of at least 5 years (National Cancer Institute, 2014).  The length of survival time 
provides a longer time interval for an opportunity of an increased risk for the post-
operative complication of lymphedema.  In fact, there is a lifetime risk for developing 
lymphedema in women who survive breast cancer (Armer & Stewart, 2010).  Prevention of 
the development of debilitating and painful lymphedema as a result of treatment for breast 
cancer should be emphasized as much as possible.  A method to decrease the risk of 
secondary lymphedema is to identify specific risk factors associated with lymphedema.  A 
study of female breast cancer survivors showed that 77% developed lymphedema within 3 
years post-operatively and linked weight gain, previous infection, or injury as a cause of the 
onset (Petrek, Senie, Peters, & Rosen, 2001).  Injury was further defined as a cut or bruise 
to the area.  This definition could be interpreted to include invasive or non-invasive 
procedures.  
 According to the National Cancer Institute (2014), “lymphedema is one of the most 
poorly understood, relatively underestimated, and least researched complications of 
cancer or its treatment” (Introduction section, para. 1).  Understanding risk factors 
associated with the development of lymphedema post-mastectomy can assist health care 










Lymphedema – What is it? 
 
Two types of lymphedema predominate in atypical conditions of the endocrine 
system.  Primary lymphedema, which is directly associated with a disease process, is not 
within the scope of this paper since it is associated with genetic abnormalities (National 
Lymphedema Network, 2015).  Secondary lymphedema is defined as protein rich fluid 
accumulating in the interstitial spaces of the body.  Secondary lymphedema related to 
women post-mastectomy is characterized by upper extremity swelling in the ipsilateral 
arm of lymph removal.  It is often described as a perception of tightness, fullness, or 
heaviness in the affected extremity and can restrict movement and range of motion, such as 
those during activities of daily living (National Cancer Institute, 2014).  Lymphedema in the 
affected limb can be painful and frequently requires interventions such as elevation and 
compression to decrease swelling, thereby relieving pain.  
Measurement of lymphedema 
 
 Measurement of lymphedema in the upper extremities occurs through a variety of 
techniques.  There are two units of measure for lymphedema; subjective and objective. 
Subjectively, women often “self-report” the symptoms of lymphedema (Geller, Vacek, 
O'Brien, & Secker-Walker, 2003).  Research questions serve to characterize and validate 




Objectively, arm circumference measurements and water displacement volumetry 
are clinical units of measure for lymphedema (Geller et al., 2003).  Other quantitative 
studies suggest that limb volume, calculated by a formula, is a more basic and easily 
reproducible measure as opposed to water displacement volumetry (Bates, Levick, & 
Mortimer, 1994).  This study also evaluated the pressure caused by interstitial fluid in the 
compartment spaces of the arm and the trends of fluid movement over a period of time 
using Starling pressures (Bates et al., 1994).  These objective measurements are not direct, 
invasive measures. However, both are used in practice today.  Although objective methods 
of measuring lymphedema in the affected arm post mastectomy are available, most 
research related to lymphedema is qualitative research and focuses on “self-report” by 
participation in a study.   
Possible factors influencing the risk of lymphedema 
Non-modifiable risk factors 
Age 
 
 Studies focusing on factors contributing to lymphedema often compare women at 
the time of lymphedema onset with their age.  One study concluded that out of multiple 
factors, age had the most significant and independent effect.  Women under the age of 50 
years have an increased risk of lymphedema post mastectomy (Geller et al., 2003).  Several 
studies showed no significant correlation between age and reflection on lymphedema risk 
(Geller et al., 2003).  Other studies found increased age (women over 50 years) to have an 
increased risk for developing lymphedema as opposed to younger women (under 50 years 
of age) (Geller et al., 2003).  Currently, the research regarding age as a non-modifiable risk 
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factor for lymphedema does not agree on whether increased age has an impact on post-
mastectomy lymphedema or not.   
Severity of disease 
 
 Cancer staging is based on the tumor node metastasis (TMN) system.  The severity, 
or stage, of breast cancer diagnosis leads women to choose the most appropriate level of 
care they receive.  If the cancer is diagnosed at an earlier stage, the standard of care for 
treatment may only include a lumpectomy.  One study stated that breast conservation 
surgery, such as lumpectomy, should be used over mastectomy to decrease the risk of 
developing lymphedema (Nesvold, Dahl, Løkkevik, Marit Mengshoel, & Fosså, 2008).  On 
the other hand, if the woman has later stage cancer, the treatment often includes 
mastectomy as well as axillary node dissection along with chemotherapy and radiation.  
Studies have shown a relationship between more aggressive treatment regimens and an 
increased risk of lymphedema on the affected side (Kim et al., 2013).  
 While the severity of the disease is a non-modifiable factor, the type of surgery is 
based on the woman’s need and the surgeon’s discretion. The term mastectomy, in this 
case, encompasses radical mastectomy but also modified radical mastectomy, simple 
mastectomy, and partial mastectomy.  The differences are the extent of the surgery. The 
partial mastectomy is closely related to a lumpectomy, where only a portion of the breast 
tumor is removed. The partial mastectomy, however, removes a larger portion of breast 
tissue, yet not the entire breast tissue (Breastcancer.org, 2015b).  
 
 6 
The simple mastectomy is the least complex surgery performed involving the 
removal of the entire breast tissue (Breastcancer.org, 2015b). The simple mastectomy is a 
common procedure for women with a lower staged cancer or for those seeking 
prophylactic measures when there is a family history of breast cancer and the risk is high 
for the woman.  
 A more complicated surgery approach is the modified radical mastectomy. This 
procedure involves removing the entire tissue from the breast and, in addition, removing 
lymph nodes.  This is the most frequently used mastectomy amongst women with breast 
cancer because the lymph node involvement provides information for staging purposes 
(Breastcancer.org, 2015b).  
 The most drastic and extensive procedure, while not widely practiced, is the radical 
mastectomy.  This procedure can be more disfiguring to the woman due to removal of not 
only the entire breast tissue and lymph nodes, but also part of the muscle within the chest 
wall.  As previously stated, this procedure is now rarely used due to statistics suggesting 
modified radical mastectomy to have similar survival outcomes to the radical mastectomy 
while sparing gross disfigurement (Breastcancer.org, 2015b).  
Axillary node resection 
 
Prior research has suggested that sentinel lymph node biopsy should decrease the 
risk of lymphedema as opposed to axillary node dissection (Pillai, Sharma, Ahmed, & 
Vijaykumar, 2010). According to a recent meta-analysis, risk for lymphedema was 4 times 
higher when women were treated with axillary lymph node dissection compared to 
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sentinel lymph node biopsy (DiSipio, Rye, Newman, & Hayes, 2013). The difference 
between axillary node dissection and sentinel lymph node biopsy is that the dissection 
removes considerably more lymph nodes than the sentinel biopsy.  
Another study showed a correlation between the numbers of lymph nodes removed, 
a woman’s BMI, and lymphedema development (Keskin et al., 2013). Since BMI can be 
considered a modifiable risk factor, women could possibly decrease the amount of lymph 
nodes needing to be removed by losing weight and therefore decrease their overall risk for 
lymphedema.  
Post Surgical Radiation and Chemotherapy  
 
  Data regarding radiation interventions or chemotherapy post mastectomy and 
lymph node removal causing lymphedema is contradicting.  One study claimed high dose 
radiation, with some radiation directly on the axilla, increases the risk of arm swelling or 
lymphedema (Geller et al., 2003).  Another study found a positive relationship between 
radiation and developing lymphedema suggesting that combining radiation with axillary 
node dissection should be avoided (Deo et al., 2004).  Conversely, there are studies that 
suggest no relationship between lymphedema and treatments, such as radiation and/or 
chemotherapy (Werner RS, 1991).  Other studies, those of Geller et al. (2003) and Kiel and 





Modifiable Risk factors 
Hypertension 
 
Studies have shown that women with arterial hypertension have a higher risk for 
post-mastectomy lymphedema (Böhler, Rhomberg, & Doringer, 1992).  In one study, 
women treated for hypertension had a decreased risk of lymphedema.  It was suggested 
that there is a need for further research comparing treated or controlled hypertension with 
medication and uncontrolled hypertension (Geller et al., 2003).  The authors based this 
need off of their own research, as well as a German study that determined hypertension to 
be a diagnosis but did not specify whether the hypertension was treated or not (Togawa et 
al., 2014).  If further research is done on hypertension and whether or not controlling it will 
decrease the risk of lymphedema, then women may have an opportunity to have more 
data-driven options to choose from and potentially decrease their risk for lymphedema.  
BMI and weight  
 
Body Mass Index or BMI is a measurement of body fat that is calculated based on a 
person’s height and weight.  A normal BMI ranges from 19 to 24, overweight ranges from 
25 to 29, obese ranges from 30 to 39, and extreme obesity is anything over 40 (National 
Institute of Health, n.d. ).  A higher BMI appears to be a risk for developing lymphedema.  
However, many studies have shown that obesity is a more commonly reported risk factor 
than BMI (Meeske et al., 2009).  While several studies showed a relationship between 
increased BMI and risk of lymphedema, others did not show any significance (Geller et al., 
2003).  The non-significant finding between BMI and weight may be due to the fact that 
data was only collected at the time of mammogram pre-diagnosis (Geller et al., 2003).  
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More comprehensive studies should be conducted on weight and the effects of developing 
lymphedema since the absence of weight gain could prevent complications. 
Current prevention of lymphedema 
 
Table 1: Treatment Characteristics 
Treatment Characteristics: Prevention Guidelines 
 Maintain healthy weight 
 Do use your affected arm for normal, everyday activities (i.e. brush hair) 
 Do not overuse affected arm 
 Avoid vigorous and repeated activities 
 Avoid heavy lifting and pulling 
 Use a fitted compression sleeve during air travel 
 Avoid immunizations in the affected arm 
 Avoid blood draws in the affected arm 
 Avoid infection 
 Push back cuticles on fingernails as opposed to cutting  
 Protect skin from insect bites, cuts, and scrapes 
 Wear thimbles for sewing 
 Wear gloves in the garden 
 Wear gloves when working with animals 
 Wear gloves when working with harsh cleaning products or steel wool 
 Be careful when shaving armpits; use a new razor on clean skin 
 Prevent falls and broken bones 
 Avoid the sun to prevent sunburn or use protective clothing and sunscreen 
 Use oven mitts that cover lower arms 
 Be careful when boiling water, frying, or removing food from microwave oven 
 Avoid high heat from hot tubs or saunas 
 Avoid constriction from tight clothing or jewelry 
 Avoid use of shoulder straps when carrying a briefcase or purse 
 Wear loose fitting bras that do not dig into shoulders 
 Have blood pressure measurements taken on unaffected arm 
 Unless both arms are affected; then use the thigh 
 
Current guidelines available for women online list multiple prevention strategies to 
avoid the possibility of lymphedema onset (American Cancer Society, 2015). 
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Providers should routinely educate women on proper precautions to prevent 
lymphedema after mastectomy surgery with axillary node removal.  Women are informed 
that any trauma to the ispilateral arm, including burns and wounds made by the puncture 
stick of a needle, can disrupt the compromised lymphatic system and increase the risk for 
lymphedema (Brennan & Weitz, 1992).  Although definite risk factors for lymphedema are 
unclear, clinicians are encouraged to cast a wide net in order to encompass any influencing 
factors from becoming a potential risk (American Cancer Society, 2015).  Currently, 
avoidance of performing invasive and non-invasive procedures to the affected arm is 
considered prudent practice.  Total avoidance of blood pressure measurements and any 
procedure, including injections or venipuncture, in the ispilateral arm may attest difficult 
























 The primary purpose of this literature review was to examine the relationship 
between blood pressure measurement and related procedures performed in the ipsilateral 
arm after mastectomy as factors leading to secondary lymphedema in post-mastectomy 
women.  The secondary purpose was to evaluate which types of risk factors increase the 
occurrence of lymphedema post mastectomy.  
Understanding risk factors for developing upper extremity lymphedema post-
mastectomy is essential for assisting women with decision-making processes regarding 
precautions and use or disuse of their ipsilateral arm for procedures.  Research is needed 
to develop evidence-based interventions to guide women about use of the ipsilateral arm 
for invasive and noninvasive procedures following mastectomy with lymph node biopsy or 
removal.  Furthermore, evidence-based guidelines are needed for all health care providers 
regarding the care of women with a risk for lymphedema following mastectomy for day-to-
day interventions requiring upper extremity access to reduce the risk of lymphedema and 











 A literature review was performed using information published from 1992 to 2015 
regarding lymphedema risk in the postoperative woman.  The information acquired over 
the 23-year span presented a comprehensive array of literature to confirm recent 
acquisitions.  CINAHL, MedLine, PsychInfo, and ERIC databases were used.  An initial search 
using the key terms lymphedema, breast cancer, mastectomy, blood pressure, infection, 
risk of lymphedema, women, post surgical, and axillary node dissection was conducted. 
 Exclusion criteria for this literature review included male gender, primary 
lymphedema, metastases, survival, quality of life (QOL) studies, reoccurrence breast 
cancer, breast conservation, lymphedema management, lymphedema only articles, and 
lymphoma.  The review process compared and contrasted the research studies on each 
factor as it contributed to being a risk factor to secondary lymphedema. Sixteen articles 
were eliminated based on the exclusion criteria. 
 A total of 22 articles were retrieved that examined a relationship between 
secondary lymphedema and use of the ipsilateral arm for invasive and non-invasive 
therapies.  Sixteen studies were utilized for including relevant criteria.   
   Additional searches were conducted manually from the article citations, which 
yielded 13 more articles of relevance, of which six were excluded due to comorbid 
conditions associated with generalized lymphedema that also included the ipsilateral arm. 
A total of 16 articles were analyzed for conclusive data related to the topic.  Any further 
information resulting from secondary lymphedema based on infection, complications, and 
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interventions performed in the ipsilateral arm was presented based on the applicability of 






















 Of the 51 articles, no studies directly addressed the relationship between blood 
pressure measurement and lymphedema development.  One article discussed a significant 
40% increase in lymphedema onset when procedures, like phlebotomy, were done in the 
ispilateral arm (Cole, 2006).  Furthermore, one article stated the invasive procedure of 
repeated finger sticks by a needle directly correlated to an increased risk of lymphedema 
(Brennan & Weitz, 1992).  
There were 16 articles that were directly relevant to secondary lymphedema risk 
factors.  Six articles stated that mastectomy verses breast conservation therapy or 
lumpectomy increased a woman’s risk of complications.  Three articles had noticed a 
correlation between chemotherapy treatment and lymphedema.  The most supported 
claim, with 12 articles, determined a direct link between an increased number of lymph 
nodes removed during an extensive axillary lymph node dissection (ALND) and 
lymphedema formation.  There were 8 articles relating radiation therapy to an increased 
risk of complications and also 8 articles supporting a relationship between a higher body 
mass index (BMI) and lymphedema.  Four studies found that an advanced diagnosis of 
breast cancer led to a higher risk of lymphedema.  Comorbidities played a role in relation to 
lymphedema, but for the purpose of this review they have been separated into 2 main 
subcategories, hypertension and diabetes mellitus.  Four studies found hypertension to be 
significant, while two studies mentioned diabetes as a pertinent risk factor.  Age is a risk 
factor, yet studies are conflicting on whether advanced age or younger age increases risk.  
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Three studies suggest that a younger age when diagnosed with breast cancer leads to an 
increased risk of developing lymphedema as a complication.  
Table 2: Risk Factors for Lymphedema 
Risk Factors for 
Lymphedema  




(Brennan & Weitz, 1992), (Cole, 2006) 2 
Mastectomy* (Cole, 2006), (Deo et al., 2004) (Hack et al., 
2010), (Nesvold et al., 2008), (Park, Lee, & 
Chung, 2008), (Togawa et al., 2014) 
6 
Radiotherapy/Radiation (Brennan & Weitz, 1992), (Cole, 2006), (Deo et 
al., 2004), (Hack et al., 2010), (Kim et al., 
2013), (Ozaslan & Kuru, 2004), (Park et al., 
2008), (Pillai et al., 2010) 
8 





(Brennan & Weitz, 1992), (Bennett Britton et 
al., 2009), (Cole, 2006), (Geller et al., 2003), 
(Meeske et al., 2009), (Hack et al., 2010), 
(Keskin et al., 2013), (Kim et al., 2013), 
(Nesvold et al., 2008), (Park et al., 2008), 
(Pillai et al., 2010), (Togawa et al., 2014) 
12 
Advanced Diagnosis (Cole, 2006), (Deo et al., 2004), (Kim et al., 
2013), (Park et al., 2008) 
4 
High BMI (Cole, 2006), (Meeske et al., 2009), (Ay, Kutun, 
& Cetin, 2014), (Keskin et al., 2013), (Nesvold 
et al., 2008), (Ozaslan & Kuru, 2004), (Park et 
al., 2008), (Togawa et al., 2014) 
8 
Hypertension (Böhler et al., 1992), (Cole, 2006), (Meeske et 
al., 2009), (Deo et al., 2004) 
4 
Advanced Age (<50) (Brennan & Weitz, 1992) 1 
Younger Age (>50) (Geller et al., 2003), (Meeske et al., 2009), 
(Hack et al., 2010) 
3 
Diabetes Mellitus  (Brennan & Weitz, 1992), (Deo et al., 2004) 2 
 
*Mastectomy term is not specific and may encompass simple mastectomy, modified radical 




Most research suggests that blood pressure measurements and related procedures 
are avoided in the ipsilateral arm after breast cancer surgery.  The reasoning for these 
guidelines are not well defined.  In fact, none of the studies demonstrated a direct 
relationship between blood pressure measurements performed on the ipsilateral arm and 
the onset of secondary lymphedema.  One study compared the current lymphedema 
prevention professional guidelines to the pathophysiology of lymphedema (Cole, 2006).  
The study found no evidence-based research supporting or not supporting the use of blood 
pressure measurements or other procedures as a risk factor for lymphedema. Until there is 
more empirical research on the topic, health care providers should continue the prudent 
practice of avoiding measurements or procedures of any type in the affected arm post 
mastectomy (Ridner, 2002).   
Invasive Procedures  
 
 Invasive procedures can range from repeated finger sticks that a person with 
diabetes may be required to use for glucose monitoring to intravenous access in order to 
receive therapy in a hospital or outpatient setting.  There was one study that focused on a 
case report of a woman who noticed arm swelling after pricking her ipsilateral arm 10 
times for blood glucose monitoring (Brennan & Weitz, 1992).  The theory behind invasive 
procedures resulting in lymphedema is associated with the inflammatory response.  It is 
believed that when the body activates the immune response to heal the trauma to the skin, 
the lymph system is compromised and can not remove the extra cells, therefore resulting in 





 The 6 studies represented in Table 2 found significant results reflecting that the 
more extensive the surgery, the higher the rate of complications.  One article compared 
multiple studies and determined that the methods reported in the studies that supported 
mastectomy as a risk factor were more thorough (Cole, 2006).  Another study determined 
that modified radical mastectomy increased the risk of lymphedema when compared to a 
partial mastectomy. This study suggested that a more complicated surgery performed 
conveyed a higher probability of lymphedema (Park et al., 2008).  Deo et al. (2004) stated 
that there was a 39% risk of lymphedema after radical mastectomy verses an 8% risk after 
lumpectomy or breast conservation.  This study had comparable results to the study done 
by Nesvold et al. (2008), which found that 20% of women with a radical mastectomy 
developed lymphedema compared to 8% of women with a breast conserving surgery.  
Women with a modified radical mastectomy experienced lymphedema more often than 
women who underwent a lumpectomy, yet no mention of how frequent was recorded 
(Hack et al., 2010).  Another study also came to the same conclusion that the modified 
radical mastectomy was associated with an increased risk of lymphedema (Togawa et al., 
2014).  According to the statistical significant studies, there is enough data to determine 
that a radical mastectomy increases the risk of lymphedema when compared to breast 





Radiation and Chemotherapy 
 
Multiple studies have identified a strong correlation between radiation therapy and 
the development of lymphedema.  One study stated that when radiation to the axilla was 
performed, the risk of lymphedema doubled (Cole, 2006).  Another study determined that 
41% of women who had axillary radiation developed lymphedema compared to 17% of 
women who had surgery only (Park et al., 2008).  A further study identified that women 
who received “radiation exposure of more than 4600 CGy” (Brennan & Weitz, 1992, p. 13), 
were at greatest risk for lymphedema.  While there is a known risk for complications after 
radiation, sometimes radiation as treatment cannot be avoided depending on the extent of 
the tumor and other factors.  The rate of occurrence for lymphedema is heightened when 
radiation is combined with chemotherapy.  Chemotherapy was found to increase the risk of 
lymphedema significantly (Geller et al., 2003).  Yet in a different study, there was no 
relationship between chemotherapy and lymphedema (Park et al., 2008).  This study 
showed the inconsistencies in data regarding chemotherapy as a risk factor and identified 
the need for further research (Park et al., 2008).  
Another study found no significance for chemotherapy alone to cause lymphedema, 
but when in combination with radiation as treatment for breast cancer, the rate is 2 to 4.5 
times more significant (Kim et al., 2013).  A study compared women who had surgery only 
with women who had surgery and radiation. This study showed that 13.4% of women with 
surgery only developed lymphedema while 42.4% of women with surgery and radiation 
developed lymphedema (Deo et al., 2004).  This study’s findings suggest an increase of 3 to 
7 more times a risk of lymphedema formation when radiation is used (Deo et al., 2004).  
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During a 6 to 12 month range after surgery, women with radiation to the axilla had a 
statistically significant risk for lymphedema (Hack et al., 2010).  Another study found 
axillary radiation to have statistical significance for lymphedema development (Pillai et al., 
2010) and there was increased risk of lymphedema by 2.75 fold in women when they 
underwent axillary radiation (Ozaslan & Kuru, 2004).  According to the studies, radiation is 
supported as an independent risk factor for the development of lymphedema post 
operatively.  
Axillary Dissection and Lymph Node Involvement  
 
 Axillary lymph node dissection has the most recognized link to lymphedema 
formation. From this review, 12 articles supported this as a tremendous risk factor. Again, 
there is a direct correlation between the higher amount of lymph nodes removed during 
the dissection and a greater risk for lymphedema formation.  One study stated that axillary 
node dissection was the best predictor of lymphedema development (Geller et al., 2003).  
Two studies reported that even when five lymph nodes were removed, there was a higher 
risk for lymphedema (Hack et al., 2010).  A multivariate study showed lymphedema to be 
associated with a greater number of lymph nodes removed (Nesvold et al., 2008).  Another 
study found a positive risk with the amount of lymph nodes removed and lymphedema.  
This study also stated that there was a significant risk when 10 or more lymph nodes were 
removed (Meeske et al., 2009).  In addition to this study, a second study also found a 
statistical significance in removing greater than 10 lymph nodes (Kim et al., 2013).  27% of 
women with greater than 10 lymph nodes removed developed lymphedema compared to 
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9% of women with less than 10 lymph nodes removed (Kim et al., 2013).  A multivariable 
analysis determined that “the risk of lymphedema increased by 5% for each lymph node 
removed” (Togawa et al., 2014, section Multivariable analyses overall, para 1).  
 When women received axillary lymph node dissection, this increased their risk of 
lymphedema by 6.61 fold (Park et al., 2008).  Another study showed a statistically 
significant risk for lymphedema when women had an aggressive lymph node involvement 
(pN3) (Pillai et al., 2010).  When these studies are reviewed, the conclusion that the risk for 
lymphedema becomes increased when there are more lymph nodes removed or there is an 
extensive axillary surgery is thoroughly supported.  These articles show a positive 
correlation between the number of lymph nodes removed and the risk for lymphedema 
development.    
Advanced Diagnosis 
 
  Breast cancer diagnosis is determined by the TNM staging system.  This system 
bases the diagnosis on the tumor size, the number of lymph nodes with cancer 
involvement, and whether or not the cancer cells have spread to other parts of the body.  
When the stage of the breast cancer diagnosis is high, the tumor is more aggressive and 
thus women are managed with a more aggressive form of treatment to eradicate the cancer 
(National Cancer Institute, 2015).  An advanced diagnosis generally involves other 
treatment options, such as a more complicated surgery combined with radiation and 
chemotherapy (Cole, 2006).  A woman with more treatments and procedures at an 
advanced diagnosis would put her at a higher risk than a woman with an early diagnosis.   
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In the univariate analysis of one study, a locally advanced cancer when compared to 
an early breast cancer was found to have a statistically significant risk for lymphedema 
(Deo et al., 2004).  Women with a higher pathologic stage (either stage II or III) had a 
statistically significant increased risk of developing lymphedema (Kim et al., 2013).  
Additionally, another study determined that women with stage II cancer had an increase 
risk of lymphedema by 2.58 fold and women with stage III cancer had an increase risk of 
lymphedema by 2.84 fold compared to women with a stage I cancer (Park et al., 2008).  
From the studies in this literature review, it seems that there is a positive correlation with 
lymphedema and the pathologic staging of cancer.  
Body Mass Index 
 
 Most studies agreed upon a high BMI correlating with an increased risk of 
lymphedema (Cole, 2006), but what each study considered a high BMI varied. A few studies 
determined women in the category of obese, BMI greater than 30, to have a higher risk of 
lymphedema. One study determined the probability of lymphedema development to be 3 
times the risk when obese (Meeske et al., 2009).  This same study found overweight 
women, BMI of 25-29, to have 2 times the risk of lymphedema when compared to women 
with a normal BMI (Meeske et al., 2009).  One study found any BMI greater than 30 to be 
significant (Ay, Kutun, & Cetin, 2014).  While another study observed the same significance 
with having a BMI greater than 30 (Togawa et al., 2014).   
Further studies defined overweight and obesity to have significance in developing 
complications.  This included those with a BMI of greater than 25 (Park et al., 2008).  Yet 
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another study had the same significance regarding a BMI of greater than 25 (Ozaslan & 
Kuru, 2004).  Other multivariate studies stated that there was a significant increase in the 
risk of lymphedema when BMI was considered (Nesvold et al., 2008). The relationship 
between weight and lymphedema may be due to hormones located within fat tissue 
(Keskin et al., 2013).  Regardless of the specific BMI the studies have outlined, the end 
result determines that being overweight or obese increases the risk for lymphedema.   
Comorbidities  
 
The comorbidities outlined within this literature review include hypertension 
(HTN) and diabetes mellitus.  The diagnosis of diabetes is a risk factor for lymphedema 
secondary to breast cancer according to two studies.  The first study determined diabetes 
to be a risk factor due to the daily maintenance of this disease, the blood glucose 
monitoring (Brennan & Weitz, 1992).  The second study grouped diabetes and 
hypertension together under the canopy of co-morbid conditions but there was statistical 
significance found to support both as being a risk factor for complications (Deo et al., 
2004).   
Cole (2006) mentioned that hypertension was a risk factor for lymphedema.  One 
retrospective study of 130 women with breast cancer showed a statistical significance that 
women with arterial hypertension had an increased risk of developing lymphedema after 
surgery (Böhler et al., 1992).  Another study determined that women with hypertension 
were twice as likely to develop lymphedema than women with normal blood pressure 
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(Meeske et al., 2009).  Although a few studies have shown statistical significance, further 
research should be conducted.   
Age 
 
 There were three studies that found women of a younger age (less than 50 years) to 
be associated with a higher chance of lymphedema development.  In one of the studies, age 
was the only independent variable for lymphedema formation and it was statistically 
significant, yet the reason for the high significance may have been due to the tendency for 
younger women to be more apt to report symptoms (Geller et al., 2003).  Another study 
found that “women diagnosed before the age of 55 were nearly twice as likely to develop 
lymphedema as those diagnosed at an older age” (Meeske et al., 2009, p. 386).  Hack et al. 
(2010), brought mention to other studies supporting that younger age played a role as a 
factor for lymphedema development, but did not include this factor in their study as 
significant.   
On the other hand, a single study supported advanced age as a risk factor for 
lymphedema.  It referred to one case study in which an 85 year-old woman developed 
lymphedema 30 years after her extensive surgery (Brennan & Weitz, 1992).  In the article 
supporting age as a significant factor, the authors have considered the reporting of the data 
to be a limitation (Geller et al., 2003).  Based off of these studies, age, whether advanced or 
not, has not received extensive research as an independent variable in order to be 




  As women are surviving breast cancer after surgery, they have an approximate 40% 
probability of developing secondary lymphedema and its associated complications (Fu, 
2014).  Healthcare providers are unaware of the triggers that set off the advancement of 
lymphedema and must utilize current practices based off of past research.  Current prudent 
practices include avoidance of procedures in the ipsilateral arm and even avoidance of hot 
tubs (Breastcancer.org, 2015a)  
At the time of this literature review, there are clinical trials involved in educating 
women with breast cancer of the signs and symptoms of lymphedema and lymphedema 
prophylaxis for women at high risk in the form of new devices (National Cancer Institute, 
n.d.).  These trials outline the need for further research on the cause of lymphedema for 
educations purposes.  Once the causes are properly identified, healthcare providers should 
be better able to assist women with options regarding use or disuse of their ipsilateral arm 
for procedures.  In turn, women may take the necessary precautions to avoid stimulating 
the process of lymphedema.   
The implications of blood pressure measurements and related procedures on the 
compromised arm have not been studied.  Based on the articles reviewed for this thesis, 
mostly retrospective studies have been conducted on this area due to the possibility of 
harm to participants. In theory, blood pressure measure taken by a manual cuff may not be 
as harmful as an automatic blood pressure cuff, due to the fact that an automatic cuff holds 
inflation longer and at higher pressures than manual measurements (American Cancer 
Society, 2015).  
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From the results of this literature review, blood pressure measurements and 
procedures in the ipsilateral arm post mastectomy as a cause of lymphedema were not 
supported  On the other hand, having a radical mastectomy, axillary radiation, extensive 
axillary dissection, having greater than 10 lymph nodes removed, and having a 
pathologically staged II or III cancer are statistically significant and supported risk factors 


















Several limitations were noted in this review of the literature.  Initial search results 
revealed numerous findings on keywords lymphedema, breast cancer, mastectomy, blood 
pressure, infection, risk of lymphedema, women, post-surgical, and axillary node 
dissection.  However, fewer original research articles remained relevant to the purpose of 
this investigation.  Only 22 initial results met inclusion criteria for this review of the 
literature.  Search terms were expanded to include citations from initial articles in order to 
provide more relevant search results.  This limitation may be an indication of the relative 
absence of specific and interactive causative factors for lymphedema in the ipsilateral arm 
post-mastectomy; thus, an indication for future research.   
 Other limitations included lymphedema measured subjectively as opposed to 
objectively.  There was no standard determinant that women based their measurement off 
of.  Measurements were conducted via “self-report” and telephone interviews, not 
numerical measurements or weights.  Furthermore, there were no articles specifically 
addressing the topic of blood pressure measurements directly causing the onset of 
secondary lymphedema in the post-surgical woman.  According to some, “self-report” may 
act as an easier clinical tool for healthcare providers to use as opposed to another objective 
measurement (Geller et al., 2003).  
 Further limitations may include demographics.  The participants in these studies 
were compliant to treatments and follow up studies.  There may be women with 
lymphedema who are unaccounted for due to not seeking care or reporting symptoms, 




The purpose of this literature review was to determine if blood pressure 
measurements or invasive procedures had a direct relationship with secondary 
lymphedema in the post-surgical woman.  The results yielded inconclusive findings.  The 
cause for secondary lymphedema is not well known and appears to be multifactorial.  Even 
with the available technology, there is no specific diagnostic test that can determine the 
cause of secondary lymphedema.  The only proposed studies that could determine if blood 
pressure measurements or invasive procedures had a direct correlation to secondary 
lymphedema could be unethical.  The reason for this would be subjecting the woman to the 
irreversible harm of an incurable complication.  
Secondary lymphedema in the post-surgical woman causes swelling, tightness, and 
physical disfigurement of the upper extremity. There is no cure for this and symptom 
management is required daily.   
Specifically, research on blood pressure measurements relating to lymphedema is 
lacking.  A manual or an automatic blood pressure cuff might be inflated to such a high 
amount that it could cause pressure to the small vessels within the ipsilateral arm.  When 
an axilla has been compromised with surgery and lymph node removal, there is resulting 
damage to the microvasculature of the arm, which may lead to the formation of 
lymphedema when pressure is applied.  Finally, the compiled results of this review of the 
literature showed no evidence of blood pressure measurements or other procedures 
performed in the ipsilateral arm post-mastectomy; therefore, neither supporting nor 
negating the cause of secondary lymphedema by blood pressure measurement.   
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Furthermore, there is insufficient evidence to suggest that procedures involving the 
ipsilateral arm after axillary node dissection will have any effect on the risk of 
lymphedema.  A prospective, randomized double blind study has yet to be conducted to 
determine if procedures on the ipsilateral arm after axillary node dissections cause 
secondary lymphedema.  A prototype study and further research into causes of upper 
extremity lymphedema in post mastectomy women has not been conducted.  Partly, this 
lack of evidence is attributable to past observations, which have alluded to a potential 
connection between invasive and non-invasive procedures and lymphedema (Cole, 2006).  
Nonetheless, the risk of lymphedema is multi-factorial in nature even when modifiable risk 
factors have been minimized.  
Further research should focus on long-term and intricate retrospective studies to 
determine factors associated with lymphedema.  Invasive procedures should continue to be 
studied. There is also a need to determine whether inflation pressures are significant when 
comparing an automatic cuff verses a manual blood pressure cuff to the risk of 
lymphedema.  Furthermore, weight reduction and hypertension may contribute to an 
increased risk of lymphedema development and further studies should be conducted to 









 In the field of nursing, this review of the literature should serve as a reminder to ask 
women if they have ever had surgery for breast cancer or if they have ever had axillary 
lymph nodes removed. Some studies have shown that not all women have been educated 
on the risks of lymphedema post operatively. As advocates for women, nurses have the 
ability to educate and reinforce the education of preventative measures by assisting 
women to find reliable resources and to ask their physicians about preventative measures. 
 Since causative factors of secondary lymphedema have not been perfectly identified, 
nurses and other healthcare providers should follow the current preventative guidelines 






































































Figure 1: Consort Diagram 
 
Key Search Terms = Breast cancer/Lymphedema*/Blood pressure 
Exclusions: Men 
 






































Potentially relevant citations identified after screening of databases 
(CINAHL, PsychINFO, ERIC, MEDLINE 
(n = 22) 
Citations excluded due to not 
meeting the inclusion criteria 
(n = 16) 
Studies retrieved for more detailed 
review 
(n = 6) 
Relevant studies included 
for further analysis which 
met all of the inclusion 
criteria 
(n = 16) 
Additional studies reviewed and selected for 
use (by hand searching credible reference 
citations)  
total n = 51 for review 
Citations added 
due to widen 
inclusion criteria 
(n = 7) 
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